Abstract
Water-soluble extracts from psoriatic scales and normal human skin were prepared using either phosphate-buffered saline, pH 7.2, or 0.1M carbonate buffer, pH 10.8. Anaphylatoxin C5a des Arg was quantified using a novel sandwich enzyme-linked immunosorbent assay (ELISA) using neoepitope-specific monoclonal antibodies. Alkali was about five to eight times more efficient than PBS in extracting C5a des Arg from scales, probably via dissociation of bound C5a des Arg. C5a des Arg concentration in scales from three patients suffering from psoriasis vulgaris varied between 2.5 and 4.6 ng/mg scale. No C5a des Arg was detectable in normal skin extracts. The biological activity of alkali-extractable C5a des Arg, i.e. chemotaxis, was preserved. The concentration of C5a des Arg relative to the concentration of albumin was taken as a parameter of the degree of complement activation in the psoriatic lesions, and was found to be more than six times higher than values attained in serum after maximum complement activation by zymosan. We conclude that complement activation may play a quantitatively important role in the inflammatory process in psoriasis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
åsbakk K, Bergh K, Iversen O-J (1990) The psoriasis-associated antigen, pso p27, participates in the formation of complement activating immune-complexes in psoriatic scale. APMIS 98: 143–149
Anttila HS, Reitamo S, Erkko P, Ceska M, Moser B, Baggiolini M (1992) Interleukin-8 immunoreactivity in the skin of healthy subjects and patients with palmoplantar pustulosis and psoriasis. J Invest Dermatol 98: 96–101
Baggiolini M, Walz A, Kunkel SL (1989) Neutrophil-activating-peptide 1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84: 1045–1049
Bergh K, Iversen O-J (1989) Measurement of complement activation in rabbit plasma and serum using monoclonal antibodies against C5a. Scand J Immunol 29: 333–341
Bergh K, Iversen O-J (1992) Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitope-specific sandwich ELISA for the quantification of C5a des Arg in plasma. J Immunol Methods 152: 79–87
Bergh K, Iversen O-J, Aasbakk K (1988) Monoclonal antibodies against the major zymosan-induced chemotactic factor in rabbit serum. J Immunol Methods 108: 179–187
Bergh K, Olsen PO, Halgunset J, Iversen O-J (1991) Complement activation and pulmonary dysfunction in experimentalEscherichia coli septicemia. Acta Anaesthesiol Scand 35: 267–274
Bigler CF, Norris DA, Weston WL, Arend WP (1992) Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol 98: 38–44
BØyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 21 [Suppl 97): 77–89
Braun-Falco O, Christophers E (1974) Structural aspects of initial psoriatic lesions. Arch Dermatol Res 251: 95–110
Camp RDR (1989) Polypeptide neutrophil chemoattractants in the skin. Dermatologica 179 [Suppl 1]: 20–24
Chenoweth DE, Hugli TE (1978) Demonstration of a specific C5a receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 75: 3943–3947
Christophers E, Schröder J-M, Mrowietz U (1989) Identification of two endogenous neutrophil-activating peptides in psoriatic skin and inflammatory cells: C5a des Arg and NAP. Dermatologica 179 [Suppl 1]: 9–15
Fincham NJ, Camp RDR, Gearing AJH, Bird CR, Cunningham FM (1988) Neutrophil chemoattractant and IL-like activity in samples from psoriatic skin lesions. Further characterisation. J Immunol 140: 4294–4299
Gahring LC, Buckley A, Daynes RA (1985) Presence of epidermal-derived thymocyte-activating factor (interleukin 1) in normal human stratum corneum. J Clin Invest 76: 1585–1591
Greaves MW, Camp RDR (1988) Prostaglandins, leukotrienes, phospholipase, platelet activating factor, and cytokines: an integrated approach to inflammation of human skin. Arch Dermatol Res 280 [Suppl]: S33–S41
Hugli TE (1984) Structure and function of the anaphylatoxins. Springer Semin Immunopathol 7: 193–219
Krogh HK, Tönder O (1973) Antibodies in psoriasis scales. Scand J Immunol 2: 45–51
Nelson RD, Quie PG, Simmons RL (1975) Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 115: 1650–1656
Okusawa S, Yancey KB, vd Meer JWM, Endres S, Lonnemann G, Hefter K, Frank MM, Burke JF, Dinarello CA, Gelfand JA (1988) C5a stimulates secretion of tumour necrosis factor from human mononuclear cells in vitro. J Exp Med 168: 443–448
Schröder J-M, Christophers E (1986) Identification of C5a des Arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J Invest Dermatol 87: 53–58
Tagami H, Kitano Y, Suehisa S, Oku T, Yamada M (1982) Psoriatic leukotactic factor. Further characterization and effect on the epidermal cells. Arch Dermatol Res 272: 201–213
Takematsu H, Ohkohchi K, Tagami H (1986) Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses. Br J Dermatol 114: 1–6
Terui T, Kato T, Tagami H (1989) Stratum corneum activation of complement through the antibody-independent alternative pathway. J Invest Dermatol 92: 593–597
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bergh, K., Iversen, O.J. & Lysvand, H. Surprisingly high levels of anaphylatoxin C5a des Arg are extractable from psoriatic scales. Arch Dermatol Res 285, 131–134 (1993). https://doi.org/10.1007/BF01112914
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01112914